Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dariusz Pytel

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisDariusz Pytel, Shelby Carter, William Hill, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|October 14, 2016
[Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment]Wioletta Rozpędek, Dariusz Pytel, J Alan Diehl, et al.
Postepy Biochemii|March 3, 2009
[Uracil-DNA glycosylases]Dariusz Pytel, Artur Słupianek, Dominika Ksiazek, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 20, 2009
Tyrosine kinase blockers: new hope for successful cancer therapyDariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|January 24, 2016
[The role of the adaptive stress response in the pathogenesis of neurodegenerative diseases, cancer and diabetes mellitus type 2]Wioletta Rozpędek, Łukasz Markiewicz, J Alan Diehl, et al.
Current Medicinal Chemistry|August 19, 2015
Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's DiseaseWioletta Rozpedek, Lukasz Markiewicz, J Alan Diehl, et al.
Biomedicines|February 10, 2021
The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell FateNatalia Siwecka, Wioletta Rozpędek-Kamińska, Adam Wawrzynkiewicz, et al.
Biomed Research International|June 30, 2015
Altered Expression Levels of MMP1, MMP9, MMP12, TIMP1, and IL-1β as a Risk Factor for the Elevated IOP and Optic Nerve Head Damage in the Primary Open-Angle Glaucoma PatientsLukasz Markiewicz, Dariusz Pytel, Bartosz Mucha, et al.
Polski Przeglad Chirurgiczny|July 14, 2017
Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatmentWioletta Rozpędek, Dariusz Pytel, Łukasz Dziki, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|February 14, 2007
Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cellsIreneusz Majsterek, Michal Arabski, Agnieszka Czechowska, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisDariusz Pytel, Shelby Carter, William Hill, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|October 14, 2016
[Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment]Wioletta Rozpędek, Dariusz Pytel, J Alan Diehl, et al.
Postepy Biochemii|March 3, 2009
[Uracil-DNA glycosylases]Dariusz Pytel, Artur Słupianek, Dominika Ksiazek, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 20, 2009
Tyrosine kinase blockers: new hope for successful cancer therapyDariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|January 24, 2016
[The role of the adaptive stress response in the pathogenesis of neurodegenerative diseases, cancer and diabetes mellitus type 2]Wioletta Rozpędek, Łukasz Markiewicz, J Alan Diehl, et al.
Current Medicinal Chemistry|August 19, 2015
Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's DiseaseWioletta Rozpedek, Lukasz Markiewicz, J Alan Diehl, et al.
Biomedicines|February 10, 2021
The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell FateNatalia Siwecka, Wioletta Rozpędek-Kamińska, Adam Wawrzynkiewicz, et al.
Biomed Research International|June 30, 2015
Altered Expression Levels of MMP1, MMP9, MMP12, TIMP1, and IL-1β as a Risk Factor for the Elevated IOP and Optic Nerve Head Damage in the Primary Open-Angle Glaucoma PatientsLukasz Markiewicz, Dariusz Pytel, Bartosz Mucha, et al.
Polski Przeglad Chirurgiczny|July 14, 2017
Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatmentWioletta Rozpędek, Dariusz Pytel, Łukasz Dziki, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|February 14, 2007
Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cellsIreneusz Majsterek, Michal Arabski, Agnieszka Czechowska, et al.
Pageof 5